The effect of secukinumab on patient-reported outcomes in patients with active psoriatic arthritis in a randomised phase 3 trial
Lancet. 2022. Epub ahead of print
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Lancet. 2022. Epub ahead of print
Ann Rheum Dis. 2022. Epub ahead of print doi: 10.1136/annrheumdis-2021-221323
RMD Open. 2022;8(1):e002012 doi: 10.1136/rmdopen-2021-002012
Rheumatology (Oxford). 2022. Epub ahead of print doi: 10.1093/rheumatology/keac068
Nat Rev Rheumatol. 2022 Jan 5:1–13. Epub ahead of print doi: 10.1038/s41584-021-00726-8
Clin Rheumatol. 2022 Jan 1. Epub ahead of print doi: 10.1007/s10067-021-05908-z
Clin Rheumatol. 2022. Epub ahead of print doi: 10.1007/s10067-021-06003-z
Ann Rheum Dis. 2022 Jan 13. Epub ahead of print doi: 10.1136/annrheumdis-2021-221915
N Engl J Med 2022;386:316–26. doi: 10.1056/NEJMc2202778
Rheumatol Ther. 2021. Epub ahead of print. doi: 10.1007/s40744-021-00390-0